Published November 8, 2018
| Supplemental Material + Published
Journal Article
Open
Optimization of Phenyl Indole Inhibitors of the AAA+ ATPase p97
Abstract
Optimization of the side-chain of a phenyl indole scaffold identified from a high-throughput screening campaign for inhibitors of the AAA+ ATPase p97 is reported. The addition of an N-alkyl piperazine led to high potency of this series in a biochemical assay, activity in cell-based assays, and excellent pharmaceutical properties. Molecular modeling based on a subsequently obtained cryo-EM structure of p97 in complex with a phenyl indole was used to rationalize the potency of these allosteric inhibitors.
Additional Information
© 2018 American Chemical Society. This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes. Received 15 August 2018. Accepted 18 September 2018. Published online 18 September 2018. Published in issue 8 November 2018. The authors gratefully acknowledge Marina Kovaliov (University of Pittsburgh) for technical support and advice; Chaemin Lim (University of Pittsburgh) for data retrieval and collation; Mary Liang (University of Pittsburgh) for compound management and extensive assistance with manuscript preparation; Taber Maskrey (University of Pittsburgh) for analytical chemistry support; Clifford Bryant (UCSF) for preliminary chemistry; Gregory Lee (UCSF) for help with data compilation; Sean Marcsisin, CTP US Army; Jason Sousa and Brittney Potter (WRAIR) for solubility data; AMRI for microsomal stability data; Richard Gussio, CAPT USPHS (NCI) for contributions to computational and molecular modeling studies; and the NCI for access to the NCI-60 cell line. The authors also appreciate the helpful discussion and suggestions of all the CBC p97 project team members, particularly Raymond Deshaies (CalTech), Eric Baldwin (Leidos), Andrew Flint (Leidos), Barbara Mroczowski (NCI), Shizuko Sei (Leidos), Gordon Stott (Leidos), Gunda Georg (University of Minnesota), and Michael Walters (University of Minnesota). The project was funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Chemical Biology Consortium Contract No. HHSN261200800001E, Agreement No. 29XS127TO15. Author Contributions: The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. The authors declare no competing financial interest.Attached Files
Published - acsmedchemlett.8b00372.pdf
Supplemental Material - ml8b00372_si_001.pdf
Files
acsmedchemlett.8b00372.pdf
Files
(6.9 MB)
Name | Size | Download all |
---|---|---|
md5:7a24e521a1f83ca9f6a408af1d480992
|
3.3 MB | Preview Download |
md5:7a9783c338dc45a79e15fedbada23cc1
|
3.6 MB | Preview Download |
Additional details
- PMCID
- PMC6231190
- Eprint ID
- 114045
- Resolver ID
- CaltechAUTHORS:20220323-565669000
- HHSN261200800001E
- NIH
- 29XS127TO15
- NIH
- Created
-
2022-03-24Created from EPrint's datestamp field
- Updated
-
2022-03-24Created from EPrint's last_modified field